#aidrugdiscovery

Investors are discussing a $2B valuation for Miles Wang's AI drug discovery startup before it has shown a pipeline.

Longevity research promises endless youth, but the science is fractured. Discover why investors should be cautious and how AI could cut drug timelines in half.

SandboxAQ is turning Claude into a front door for scientific models, betting AI drug discovery needs easier access more than hype.

In 2024, technology is accelerating at an unprecedented pace. From quantum processors with 1,000+ qubits to AI models that design drug molecules in months inste

In the sterile corridors of pharmaceutical giants and the cluttered laboratories of biotech startups,...